Common Contracts
2 similar Exclusive License and Supply Agreement contracts by Protalix BioTherapeutics, Inc.
EXCLUSIVE U.S. LICENSE AND SUPPLY AGREEMENT by and between CHIESI FARMACEUTICI S.p.A. and PROTALIX LTD. JULY 23, 2018Exclusive License and Supply Agreement • November 7th, 2018 • Protalix BioTherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Exclusive U.S. License and Supply Agreement (this “Agreement”) dated as of the 23rd day of July, 2018 is made by and between Protalix Ltd., a limited liability company incorporated under the laws of Israel with offices located at 2 Snunit Street, Science Park, P.O. Box 455, Carmiel 20100, Israel (“Protalix”), and Chiesi Farmaceutici S.p.A., a company incorporated under the laws of Italy with offices located at Largo F. Belloli, 11/A, 43122 Parma, Italy (“Chiesi”) (each, a “Party” and collectively, the “Parties”).
Portions of this exhibit have been omitted pursuant to a request for confidential treatment pursuant to 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2(b). The omitted portions, marked by [***], have been separately filed with the Securities and...Exclusive License and Supply Agreement • March 6th, 2018 • Protalix BioTherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Exclusive License and Supply Agreement (this “Agreement”) dated as of the 17th day of October, 2017 is made by and between Protalix Ltd., a limited liability company incorporated under the laws of Israel with offices located at 2 Snunit Street, Science Park, P.O. Box 455, Carmiel 20100, Israel (“Protalix”), and Chiesi Farmaceutici S.p.A., a company incorporated under the laws of Italy with offices located at Largo F. Belloli, 11/A - 43122 Parma, Italy (“Chiesi”) (each, a “Party” and collectively, the “Parties”).
